Veritas Genetics Halts US Operations, Lays Off More Than 30

Dec 05, 2019

|

NEW YORK – Veritas Genetics is shutting down its US operations, at least temporarily, due to financial troubles.

Mirza Cifric, the company's CEO, told GenomeWeb that the firm ran out of funds because a planned financing fell through, which was "very abrupt and unexpected," and that it started laying off most of its US staff, more than 30 employees, earlier this week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Hoax Account Uncovered

The founder of MeTooSTEM, BethAnn McLaughlin, created a Twitter account purported to be that of an LGBTQ Native American professor at Arizona State University, the New York Times writes.

More Promising Results

Novavax reports its candidate SARS-CoV-2 vaccine leads to immune responses, according to the Sydney Morning Herald.

All Ready for Shark Week?

Gene length is associated with lifespan in a comparative genomics study appearing in the Proceedings of the National Academy of Sciences that draws on the whale shark genome.

Nucleic Acids Research Studies on Rat Transcriptome, Marine Metagenomic Tool, More

In Nucleic Acids Research this week: effort to annotate the rat transcriptome, web-based resource to characterize marine microbes, and more.

Featured White Papers

Delivering Rapid Whole Genome Reports for ICU Cases with Opal Clinical STAT

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

AnyDeplete - A customizable depletion solution for RNA-Seq workflows

95 MDAF: Modeling Noise in Archer NGS Data with Per-Base Resolution for Statistically Informed, Position-Dependent Variant Calling

Aug

13

Featured Webinar

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.

Aug

18

Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug

24

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Sep

01

Featured Webinar

Application of Whole-Exome Sequencing in Neurodevelopmental Disorders Research

This webinar will address the utility of exome sequencing for neurodevelopmental disorders research and will provide details of a comparison study of two exome probe kits in this field of study.

Menu

Veritas Genetics Halts US Operations, Lays Off More Than 30

To read the full story....

Breaking News

Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay

PavMed Raises $7M in Private Funding Round

GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer

Biocept, Aegea to Develop PCR-based COVID-19 Assay Using Switch-Blocker Tech

IncellDx, Factorial Diagnostics Ink Licensing, Supply Agreement

Becton Dickinson Fiscal Q3 Revenues Drop 11 Percent

The Scan

Hoax Account Uncovered

More Promising Results

All Ready for Shark Week?

Nucleic Acids Research Studies on Rat Transcriptome, Marine Metagenomic Tool, More

Featured White Papers

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

Utility of Novel RNA-Based Tools in Oncology Drug Development

Application of Whole-Exome Sequencing in Neurodevelopmental Disorders Research

What's Popular?

Blackstone to Acquire Ancestry for $4.7B

All-Cause Mortality Associated With New Sex-Specific Polygenic Risk Scores

Ancestry Rolls Out Sequencing-Based Health Offering Focused on Common Conditions

Veracyte Prices $180M Public Stock Offering

Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay

Sponsorships